Expression Table for this CRE
| CNhs10596 | forelimb, embryo E11 | 304.9 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 294.6 |
| SRX7078887 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 282.9 |
| SRX7078886 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 237.8 |
| CNhs11214 | kidney, neonate N00 | 197.0 |
| CNhs11195 | bone (os femoris), neonate N20 | 153.2 |
| CNhs11037 | pituitary gland, embryo E14 | 86.1 |
| CNhs13688 | EBF KO HPCs induced to T cell, 00hr30min, biol_rep3 | 69.1 |
| CNhs13687 | EBF KO HPCs induced to T cell, 00hr00min, biol_rep3 | 53.0 |
| SRX10234855 | Lung smooth muscle cells of C57BL/6 strain WT mouse | 44.7 |
| CNhs14383 | natural helper cells, IL33 treated, 01hr, biol_rep1 | 40.0 |
| SRX690783 | Mdr2-KO liver male etiology/histology:10% AD, 60% HCC | 39.9 |
| CNhs14301 | macrophage, TB infection, non-stimulated BMDM, without Mtb, 120hr, biol_rep3 | 38.1 |
| SRX10234854 | Lung smooth muscle cells of C57BL/6 strain WT mouse | 34.8 |
| CNhs14335 | natural helper cells, IL2 treated, day15, biol_rep3 | 34.0 |
| SRX690784 | Mdr2-KO liver male etiology/histology:0% AD, 60% HCC | 30.5 |
| CNhs10580 | pancreas, embryo E18 | 29.4 |
| CNhs12683 | J2E erythroblastic leukemia response to erythropoietin, 48hr, biol_rep2 | 28.8 |
| SRX10234856 | Lung smooth muscle cells of C57BL/6 strain TET3 KO mouse | 28.5 |
| SRX690782 | Mdr2-KO liver female etiology/histology:10% AD, 60% HCC | 26.7 |
| SRX10234857 | Lung smooth muscle cells of C57BL/6 strain TET3 KO mouse | 26.2 |
| CNhs12682 | J2E erythroblastic leukemia response to erythropoietin, 24hr, biol_rep2 | 24.4 |
| CNhs12785 | J2E erythroblastic leukemia response to erythropoietin, 48hr, biol_rep3 | 23.4 |
| CNhs12579 | natural helper cells, IL33 treated, 01hr, biol_rep1 | 22.6 |
| CNhs11220 | liver, neonate N20 | 22.0 |
| CNhs11493 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 120hr, biol_rep1 | 21.6 |
| CNhs14300 | macrophage, TB infection, non-stimulated BMDM, without Mtb, 072hr, biol_rep3 | 20.9 |
| CNhs12782 | J2E erythroblastic leukemia response to erythropoietin, 06hr, biol_rep3 | 20.8 |
| CNhs10585 | intestine, embryo E16 | 20.7 |
| CNhs11019 | intestine, embryo E12 | 20.1 |
| CNhs12783 | J2E erythroblastic leukemia response to erythropoietin, 12hr, biol_rep3 | 20.0 |
| DRX055013 | OP27 with Evi1-specific shRNA 30 min after induced by 5 mM EDTA in PBS rep1 | 19.9 |
| CNhs10597 | heart, embryo E14 | 19.8 |
| CNhs11133 | lung, neonate N30 | 19.4 |
| CNhs11469 | macrophage, TB infection, stimulated BMDM+IFNg(caMph), without Mtb, 028hr, biol_rep1 | 19.3 |
| CNhs12456 | J2E erythroblastic leukemia response to erythropoietin, 48hr, biol_rep1 | 19.1 |
| CNhs10584 | kidney, embryo E16 | 18.8 |
| CNhs12777 | J2E erythroblastic leukemia response to erythropoietin, 02hr00min, biol_rep3 | 18.8 |
| CNhs14125 | ES-46C derived epistem cells, biol_rep3 | 18.6 |
| CNhs13115 | ST2 (Mesenchymal stem cells) cells, differentiation to adipocytes, 00hr30min, biol_rep1 (030mA1) | 18.6 |
| CNhs13019 | cerebellum, embryo E16, biol_rep3 (E16R3) | 18.2 |
| CNhs13140 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, day02, biol_rep1 (048hB1) | 18.0 |
| CNhs12784 | J2E erythroblastic leukemia response to erythropoietin, 24hr, biol_rep3 | 17.8 |
| CNhs13131 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 00hr30min, biol_rep1 (030mB1) | 17.7 |
| CNhs14517 | hepatic stellate cells, partial hepatectomy, week01, biol_rep1 | 17.7 |
| CNhs11132 | thymus, neonate N30 | 17.6 |
| CNhs13088 | neurospheres - enteric neuron derived, biol_rep2 | 17.5 |
| CNhs11206 | kidney, neonate N10 | 17.5 |
| SRX690779 | Mdr2-KO liver male etiology/histology:20% AD, 70% HCC | 17.4 |
| CNhs11484 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 002hr, biol_rep1 | 17.3 |